MYH9 is associated with nondiabetic end-stage renal disease in African Americans

W.H. Linda Kao(Johns Hopkins University), Michael J. Klag(Johns Hopkins University), Lucy A. Meoni(Johns Hopkins University), David Reich(Harvard University), Yvette Berthier‐Schaad(Johns Hopkins University), Man Li(Johns Hopkins University), Josef Coresh(Johns Hopkins University), Nick Patterson(Broad Institute), Arti Tandon(Harvard University), Neil R. Powe(Johns Hopkins University), Nancy E. Fink(Johns Hopkins University), John H. Sadler(University of Maryland, Baltimore), Matthew R. Weir(University of Maryland, Baltimore), Hanna E. Abboud(The University of Texas Health Science Center at San Antonio), Sharon G. Adler(The Lundquist Institute), Jasmin Divers(Wake Forest University), Sudha K. Iyengar(Case Western Reserve University), Barry I. Freedman(Wake Forest University), Paul L. Kimmel(National Institutes of Health), William C. Knowler(National Institute of Diabetes and Digestive and Kidney Diseases), O. Köhn(Loyola University Chicago), Kristopher Kramp(Case Western Reserve University), David J. Leehey(University of Chicago), Susanne B. Nicholas(University of California, Los Angeles), Madeleine V. Pahl(University of California, Irvine), Jeffrey R. Schelling(Case Western Reserve University), John R. Sedor(Case Western Reserve University), Denyse Thornley‐Brown(University of Alabama at Birmingham), Cheryl A. Winkler(Science Applications International Corporation (United States)), Michael W. Smith(Science Applications International Corporation (United States)), Rulan S. Parekh(Johns Hopkins Medicine)
Nature Genetics
September 11, 2008
Cited by 645Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis